@ILROGTeam @ASTRO_org @ASH_hematology @ASCO @LLSusa @lymphoma @MDAndersonNews download the easy visual mini-atlas part I for @ASH_hematology radiation fields guide, part II coming soon!!!.t https://t.co/fGmc4Ze8UY. @ASTRO_org @MDAndersonNews @ASCO @ARRO_org @TaniguchiMD @lymphoma @LLSusa @Lymphoma_Papers https://t.co/JvwRPKwDdE
Making Every Single Gray Count: Involved Site Radiation Therapy Delineation Guidelines for Hematological Malignancies.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jan 2020 – May 2022Where it's discussed
-
X / Twitter17 posts
-
YouTube4 videos
AI synopsis
What people are saying
The discussions reflect a supportive attitude toward the guidelines, with posts mentioning specific constraints like '5 Gy IDL' and consolidation techniques for larger areas, which illustrate technical engagement. The tone is professional and focused on practical application, emphasizing the importance of standardization and precision in radiation therapy for hematological cancers, thus indicating a moderate but meaningful impact on clinical practices.
Most discussions support the importance and utility of the guidelines, indicating a general agreement with their value.
Participants show moderate interest, often referencing specific constraints, methods, or related tools, but the overall tone remains professional and somewhat reserved.
Posts include technical details, such as dimensions for consolidating radiation fields and referencing visual guides, demonstrating active engagement.
The emphasis on implementing guideline recommendations and referencing supporting tools suggest the discussions recognize a meaningful potential to influence clinical practice.
Abstract in brief
- The document focuses on guidelines for accurately defining radiation therapy target areas in patients with hematological cancers to improve treatment effectiveness.
- It emphasizes the importance of careful delineation of every gray zone, or uncertain area, to ensure precise radiation delivery and minimize damage to healthy tissue.
- The guidelines aim to standardize practices across different sites to enhance consistency and outcomes in radiation therapy for hematological malignancies.]
Top posts
Most liked on X and Bluesky@drbeckta @NicholasZaorsky @CunninghamOnc @JillGunther @ILROGTeam Hah! Glad you asked. Peds and heme are the only scenarios where I care about 5 Gy IDL. Easy heme constraints:
@SanghviMd @AaronGoodman33 Nailed it! Also, I tend to consolidate if >5 cm in any direction, CT-based resid >2cm, or high risk for complications from LR (e.g., cord/SRE). Of course, keep 5-15 Gy IDL out of OARs. Modern techniques, ftw!
@_katelynatkins @avirupguha @HinaSaeedMD @AmishiBajajMD @Rad_Nation @subatomicdoc @BreastDocUK @IanJPereira @MonaArbabMD @ChaurasiaMD @NorthwesternMed @Dr_RayMak @KathrynBanfill Here are NCCN gastric constraints - seem to hover around 30 Gy. For MALT, could likely invoke ILROG recs to keep 5 Gy IDL out of surrounding organs at risk - including ❤️. #ALARA #radonc #jc T4 - but for other malignancies
Making Every Single Gray Count: Involved Site Radiation Therapy Delineation Guidelines for Hematological Malignancies - ScienceDirect https://t.co/EV79TyZ0EI
RT @BouthainaDabaja: @ILROGTeam @ASTRO_org @ASH_hematology @ASCO @LLSusa @lymphoma @MDAndersonNews download the easy visual mini-atlas part…
All mentions
Radiation Therapy Strategies for NK/T-Cell Lymphoma Effectiveness and Guidelines
Dr. Bouthaina Dabaja discusses the use of radiation therapy in managing NK/T-cell lymphoma, emphasizing precise target delineation to optimize treatment outcomes and minimize healthy tissue damage according to…
Radiation Therapy for Lymphoma of the Mesentery Explained
Dr. Dabaja discusses radiation therapy's role in treating lymphoma of the mesentery, emphasizing accurate target delineation to improve treatment effectiveness and reduce healthy tissue damage, based on recent…
Radiation Therapy Advances in Managing Gastric Lymphoma
Bouthaina Dabaja MD discusses the use of radiation therapy in the management of gastric lymphoma, emphasizing precise target delineation guidelines for hematological malignancies to improve treatment effectiveness and…
Radiation Therapy for Head and Neck Lymphoma: Guidelines and Techniques
Dr. Dabaja discusses how radiation therapy is used to treat lymphoma in the head and neck, emphasizing the importance of precise target delineation to improve treatment effectiveness and reduce harm to healthy tissue.
@drbeckta @NicholasZaorsky @CunninghamOnc @JillGunther @ILROGTeam Hah! Glad you asked. Peds and heme are the only scenarios where I care about 5 Gy IDL. Easy heme constraints:
RT @jryckman3: @SanghviMd @AaronGoodman33 Nailed it! Also, I tend to consolidate if >5 cm in any direction, CT-based resid >2cm, or high ri…
RT @jryckman3: @SanghviMd @AaronGoodman33 Nailed it! Also, I tend to consolidate if >5 cm in any direction, CT-based resid >2cm, or high ri…
@SanghviMd @AaronGoodman33 Nailed it! Also, I tend to consolidate if >5 cm in any direction, CT-based resid >2cm, or high risk for complications from LR (e.g., cord/SRE). Of course, keep 5-15 Gy IDL out of OARs. Modern techniques, ftw!
@_katelynatkins @avirupguha @HinaSaeedMD @AmishiBajajMD @Rad_Nation @subatomicdoc @BreastDocUK @IanJPereira @MonaArbabMD @ChaurasiaMD @NorthwesternMed @Dr_RayMak @KathrynBanfill Here are NCCN gastric constraints - seem to hover around 30 Gy. For MALT, could likely invoke ILROG recs to keep 5 Gy IDL out of surrounding organs at risk - including ❤️. #ALARA #radonc #jc T4 - but for other malignancies
RT @BouthainaDabaja: @ILROGTeam @ASTRO_org @ASH_hematology @ASCO @LLSusa @lymphoma @MDAndersonNews download the easy visual mini-atlas part…
RT @BouthainaDabaja: @ILROGTeam @ASTRO_org @ASH_hematology @ASCO @LLSusa @lymphoma @MDAndersonNews download the easy visual mini-atlas part…
RT @BouthainaDabaja: @ILROGTeam @ASTRO_org @ASH_hematology @ASCO @LLSusa @lymphoma @MDAndersonNews download the easy visual mini-atlas part…
RT @BouthainaDabaja: @ILROGTeam @ASTRO_org @ASH_hematology @ASCO @LLSusa @lymphoma @MDAndersonNews download the easy visual mini-atlas part…
RT @BouthainaDabaja: @ILROGTeam @ASTRO_org @ASH_hematology @ASCO @LLSusa @lymphoma @MDAndersonNews download the easy visual mini-atlas part…
RT @BouthainaDabaja: @ILROGTeam @ASTRO_org @ASH_hematology @ASCO @LLSusa @lymphoma @MDAndersonNews download the easy visual mini-atlas part…
RT @BouthainaDabaja: @ILROGTeam @ASTRO_org @ASH_hematology @ASCO @LLSusa @lymphoma @MDAndersonNews download the easy visual mini-atlas part…
RT @BouthainaDabaja: @ILROGTeam @ASTRO_org @ASH_hematology @ASCO @LLSusa @lymphoma @MDAndersonNews download the easy visual mini-atlas part…
@ILROGTeam @ASTRO_org @ASH_hematology @ASCO @LLSusa @lymphoma @MDAndersonNews download the easy visual mini-atlas part I for @ASH_hematology radiation fields guide, part II coming soon!!!.t https://t.co/fGmc4Ze8UY. @ASTRO_org @MDAndersonNews @ASCO @ARRO_org @TaniguchiMD @lymphoma @LLSusa @Lymphoma_Papers https://t.co/JvwRPKwDdE
Making Every Single Gray Count: Involved Site Radiation Therapy Delineation Guidelines for Hematological Malignancies - ScienceDirect https://t.co/EV79TyZ0EI
Making Every Single Gray Count: Involved Site Radiation Therapy Delineation Guidelines for Hematological Malignancies https://t.co/GaOYW7wgf4
IJROBP: "Making Every Single Gray Count: Involved Site Radiation Therapy Delineation Guidelines for Hematological Malignancies" https://t.co/sjQXB0s4ri